We are live on ! Find out more
TENX icon

Tenax Therapeutics
TENX

16 hedge funds and large institutions have $1.6M invested in Tenax Therapeutics in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

7% more funds holding

Funds holding: 15 → 16 (+1)

0% less ownership

Funds ownership: 0.02% → 0.02% (-0%)

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

76% less capital invested

Capital invested by funds: $6.54M → $1.6M (-$4.94M)

Holders
16
Holders Change
+1
Holders Change %
+6.67%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$46.1K
2
TSS
Two Sigma Securities
New York
+$12K
3
Citigroup
Citigroup
New York
+$8.01K
4
Millennium Management
Millennium Management
New York
+$7.01K
5
TRCT
Tower Research Capital (TRC)
New York
+$3K

Top Sellers

Rank Fund Capital Flow
1
IC
Ikarian Capital
Texas
-$596K
2
AC
Armistice Capital
New York
-$264K
3
BFM
Boothbay Fund Management
New York
-$58K
4
BlackRock
BlackRock
New York
-$20K
5
HF
HRT Financial
New York
-$8K
Name Holding Trade Value Shares
Change 		Change in
Stake
GG
1
Gofen & Glossberg
Illinois
$1.15M – – –
BlackRock
2
BlackRock
New York
$144K -$20K -20 -6%
Vanguard Group
3
Vanguard Group
Pennsylvania
$108K – – –
PNC Financial Services Group
4
PNC Financial Services Group
Pennsylvania
$60K – – –
State Street
5
State Street
Massachusetts
$42K – – –
Citadel Advisors
6
Citadel Advisors
Florida
$22K +$46.1K +46 New
Renaissance Technologies
7
Renaissance Technologies
New York
$20K -$1K -1 -2%
FWP
8
FAS Wealth Partners
Kansas
$17K – – –
Geode Capital Management
9
Geode Capital Management
Massachusetts
$15K – – –
Northern Trust
10
Northern Trust
Illinois
$10K – – –
TSS
11
Two Sigma Securities
New York
$6K +$12K +12 New
Citigroup
12
Citigroup
New York
$4K +$8.01K +8 New
TRCT
13
Tower Research Capital (TRC)
New York
$3K +$3K +3 +100%
Millennium Management
14
Millennium Management
New York
$3K +$7.01K +7 New
AC
15
Armistice Capital
New York
$479 -$264K -264 -21%
IC
16
Ikarian Capital
Texas
– -$596K -459 Closed
BFM
17
Boothbay Fund Management
New York
– -$58K -45 Closed
HF
18
HRT Financial
New York
– -$8K -7 Closed

TENX Hedge Fund Activity: Q2 2022 in Review

16 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q2 2022, worth a combined $1.6M — down 76% from $6.54M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new TENX positions and 3 closed out — a net gain of 1 holder — while 1 added to existing stakes and 3 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $46.1K. The largest seller was Ikarian Capital, exiting entirely with an estimated $596K sold.

  • 16 institutional investors held Tenax Therapeutics (TENX) as of Q2 2022, up from 15 in Q1 2022.
  • Funds reported $1.6M of Tenax Therapeutics stock for Q2 2022, down 76% quarter-over-quarter.
  • 4 funds opened new Tenax Therapeutics positions in Q2 2022 and 3 closed out, a net change of +1 holder.
  • The largest Tenax Therapeutics buyer in Q2 2022 was Citadel Advisors, an estimated $46.1K added.
  • The largest Tenax Therapeutics seller in Q2 2022 was Ikarian Capital, an estimated $596K sold.

Based on aggregated 13F filings for Q2 2022.